Drug stocks hug flat line; Cell Therapeutics gains
June 24, 2009 at 10:14 AM EDT
Drug stocks hug the flat line as shares of Cell Therapeutics Inc. advanced on news that it has fully submitted its application to U.S. regulators to market its new oncology drug pixantrone.
